Tsunehiko Soga

914 total citations
36 papers, 711 citations indexed

About

Tsunehiko Soga is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Tsunehiko Soga has authored 36 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 20 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Tsunehiko Soga's work include Cancer Treatment and Pharmacology (13 papers), Synthetic Organic Chemistry Methods (7 papers) and Microbial Natural Products and Biosynthesis (6 papers). Tsunehiko Soga is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Synthetic Organic Chemistry Methods (7 papers) and Microbial Natural Products and Biosynthesis (6 papers). Tsunehiko Soga collaborates with scholars based in Japan and Germany. Tsunehiko Soga's co-authors include Kouichi Uoto, Jun Chiba, Takao Horiuchi, Hirofumi Terasawa, Kazuo Achiwa, Mayumi Kitagawa, Kenji Koga, Kazunori Odashima, Akiko Tohgo and Takeshi Jimbo and has published in prestigious journals such as Tetrahedron Letters, Bioorganic & Medicinal Chemistry and Cancer Science.

In The Last Decade

Tsunehiko Soga

36 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsunehiko Soga Japan 16 420 307 207 73 70 36 711
Kouichi Uoto Japan 18 517 1.2× 389 1.3× 292 1.4× 83 1.1× 76 1.1× 45 939
Stephen L. Gwaltney United States 17 540 1.3× 478 1.6× 391 1.9× 42 0.6× 32 0.5× 25 1.3k
Anne Mengel Germany 12 623 1.5× 414 1.3× 88 0.4× 92 1.3× 26 0.4× 18 967
Kenneth A. Savin United States 14 657 1.6× 353 1.1× 306 1.5× 56 0.8× 47 0.7× 18 1.1k
Alexey Rivkin United States 18 592 1.4× 286 0.9× 263 1.3× 57 0.8× 75 1.1× 28 863
Kurt Eger Germany 18 532 1.3× 428 1.4× 84 0.4× 25 0.3× 32 0.5× 76 1.0k
Laurent Schio France 15 486 1.2× 344 1.1× 76 0.4× 61 0.8× 34 0.5× 29 1.0k
T. L. MACDONALD United States 11 425 1.0× 239 0.8× 123 0.6× 56 0.8× 38 0.5× 19 694
Philippe L. Durette United States 16 547 1.3× 447 1.5× 114 0.6× 34 0.5× 33 0.5× 42 869
Gianfranco Battistuzzi Italy 17 750 1.8× 388 1.3× 155 0.7× 77 1.1× 25 0.4× 31 1.1k

Countries citing papers authored by Tsunehiko Soga

Since Specialization
Citations

This map shows the geographic impact of Tsunehiko Soga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsunehiko Soga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsunehiko Soga more than expected).

Fields of papers citing papers by Tsunehiko Soga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsunehiko Soga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsunehiko Soga. The network helps show where Tsunehiko Soga may publish in the future.

Co-authorship network of co-authors of Tsunehiko Soga

This figure shows the co-authorship network connecting the top 25 collaborators of Tsunehiko Soga. A scholar is included among the top collaborators of Tsunehiko Soga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsunehiko Soga. Tsunehiko Soga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Masaki, Masaki Miyazaki, Kouichi Uoto, et al.. (2015). Discovery of DS-5272 as a promising candidate: A potent and orally active p53–MDM2 interaction inhibitor. Bioorganic & Medicinal Chemistry. 23(10). 2360–2367. 31 indexed citations
2.
Miyazaki, Masaki, Masaki Miyazaki, Hiroyuki Naito, et al.. (2013). Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors. Bioorganic & Medicinal Chemistry. 21(14). 4319–4331. 26 indexed citations
3.
Miyazaki, Masaki, Masaki Miyazaki, Haruko C. Kawato, et al.. (2012). Discovery of novel dihydroimidazothiazole derivatives as p53–MDM2 protein–protein interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 22(20). 6338–6342. 15 indexed citations
4.
Miyazaki, Masaki, Masaki Miyazaki, Hiroyuki Naito, et al.. (2012). Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold. Bioorganic & Medicinal Chemistry Letters. 23(3). 728–732. 25 indexed citations
5.
Horiuchi, Takao, Jun Chiba, Kouichi Uoto, & Tsunehiko Soga. (2008). Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 19(2). 305–308. 85 indexed citations
6.
Takeda, Yasuyuki, Kouichi Uoto, Michio Iwahana, et al.. (2004). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 5. Bioorganic & Medicinal Chemistry Letters. 14(12). 3209–3215. 2 indexed citations
7.
Jimbo, Takeshi, et al.. (2003). DJ‐927, a novel oral taxane, overcomes P‐glycoprotein‐mediated multidrug resistance in vitro and in vivo. Cancer Science. 94(5). 459–466. 67 indexed citations
8.
Takeda, Yasuyuki, Kouichi Uoto, Jun Chiba, et al.. (2003). New highly active taxoids from 9β-Dihydrobaccatin-9,10-acetals. Part 4. Bioorganic & Medicinal Chemistry. 11(20). 4431–4447. 14 indexed citations
9.
Takeda, Yasuyuki, Toshiharu Yoshino, Kouichi Uoto, et al.. (2003). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 3. Bioorganic & Medicinal Chemistry Letters. 13(2). 185–190. 17 indexed citations
10.
Ishiyama, Takashi, Shin Iimura, Satoru Ohsuki, et al.. (2002). New highly active taxoids from 9β-Dihydrobaccatin-9,10-acetals. Bioorganic & Medicinal Chemistry Letters. 12(7). 1083–1086. 21 indexed citations
11.
Ishiyama, Takashi, Shin Iimura, Toshiharu Yoshino, et al.. (2002). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 2. Bioorganic & Medicinal Chemistry Letters. 12(20). 2815–2819. 6 indexed citations
12.
Nakayama, Kiyoshi, Hirofumi Terasawa, Ikuo Mitsui, et al.. (1998). Synthesis and cytotoxic activity of novel 10-alkylated docetaxel analogs. Bioorganic & Medicinal Chemistry Letters. 8(5). 427–432. 6 indexed citations
13.
Uoto, Kouichi, Satoru Ohsuki, Takashi Ishiyama, et al.. (1997). Synthesis and Structure-Activity Relationships of Novel 2',2'-Difluoro Analogues of Docetaxel.. Chemical and Pharmaceutical Bulletin. 45(11). 1793–1804. 72 indexed citations
14.
Uoto, Kouichi, Ikuo Mitsui, Hirofumi Terasawa, & Tsunehiko Soga. (1997). First synthesis and cytotoxic activity of novel docetaxel analogs modified at the C18-position. Bioorganic & Medicinal Chemistry Letters. 7(23). 2991–2996. 6 indexed citations
15.
Higashi, Kunio, et al.. (1994). Synthesis and antibacterial activity of new 2-substituted penems. II.. The Journal of Antibiotics. 47(3). 357–369. 8 indexed citations
16.
17.
Soga, Tsunehiko, et al.. (1991). Reactions of α,β-Unsaturated Ketone Acetals with Trimethylsilyl Cyanide and Trimethylsilyl Sulfides. Bulletin of the Chemical Society of Japan. 64(4). 1108–1117. 4 indexed citations
18.
19.
Soga, Tsunehiko, Kiyoshi Nakayama, Hiroto Nakajima, et al.. (1990). Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with .ALPHA.- or .BETA.-configuration at position 1.. Chemical and Pharmaceutical Bulletin. 38(12). 3366–3372. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kouichi Uoto Breakdown of academic impact, for papers by Stephen L. Gwaltney Breakdown of academic impact, for papers by Anne Mengel Breakdown of academic impact, for papers by Kenneth A. Savin Breakdown of academic impact, for papers by Alexey Rivkin Breakdown of academic impact, for papers by Kurt Eger Breakdown of academic impact, for papers by Laurent Schio Breakdown of academic impact, for papers by T. L. MACDONALD Breakdown of academic impact, for papers by Philippe L. Durette Breakdown of academic impact, for papers by Gianfranco Battistuzzi
Rankless by CCL
2026